Clarix
Formulas

Creating a Formula

Step-by-step guide to creating a new Master Formula Record (MFR) using the five-step New Formula wizard in Clarix.

Creating a Master Formula Record (MFR) in Clarix uses a structured five-step wizard that captures all the core attributes of a compound before you begin adding ingredients and manufacturing steps. The wizard keeps you on track and prevents you from saving an incomplete formula shell.

New formula form

Role required: Compounder, PIC, or QA Manager role is required to create formulas.

Before you begin

Gather the following information before starting the wizard:

  • Product name and any internal product code your facility uses
  • Strength (e.g., 10 mg/mL) and dosage form
  • Intended batch size and unit
  • BUD category and day count (consult your pharmacy's SOPs and USP ⟨797⟩/⟨795⟩)
  • Storage requirements for the finished product
  • Risk level designation per your facility's risk assessment

Opening the wizard

  1. In the left sidebar, click Formulas.
  2. Click the New Formula button in the top-right corner of the formula catalog page.
  3. The five-step wizard opens as a full-page form.

Step 1 — Product identity

This step establishes the core identity of the compound.

FieldDescription
Product nameFull descriptive name, e.g., "Famotidine 4 mg/mL Injectable Solution"
Product codeYour facility's internal code (optional but recommended for barcode matching)
StrengthConcentration or potency, e.g., "4 mg/mL" or "200 mg/5 mL"
Dosage formSelect from the dropdown: Injectable Solution, Injectable Suspension, Ophthalmic, Otic, Oral Solution, Oral Suspension, Topical Cream, Topical Gel, Suppository, Capsule, Other

Click Next when complete. All fields except Product code are required.


Step 2 — Batch size and unit

Specify how large a single production run of this formula will be.

FieldDescription
Batch sizeA positive number representing the total yield (e.g., 2500)
UnitSelect the unit: mL, L, g, kg, units, capsules, patches

The batch size entered here is stored as the batchSize variable available in calculation steps. When a batch is created from this formula, the actual yield may vary, but calculation steps will always reference this target size.

Click Next when complete.


Step 3 — Beyond-Use Date (BUD)

The BUD tells dispensers how long the finished product can be used after compounding. Clarix presents a category selector that enforces the correct framework depending on product type.

Sterile products (USP ⟨797⟩):

CategoryMaximum BUDTypical use
Category 11 day (24 hours) at room temp, or 4 days refrigeratedImmediate-use or low-risk preparations without sterility testing
Category 2Up to 45 days at room temp or 60 days refrigeratedPreparations with extended dating supported by facility-specific testing
Category 3Based on stability study data — enter study-supported daysProducts with container/closure and stability data

Non-sterile products (USP ⟨795⟩):

TypeGuidance
Non-aqueous preparationsUp to 180 days (enter the specific day count)
Water-containing oralUp to 14 days refrigerated
Water-containing topical/mucosalUp to 30 days
OtherEnter the facility SOP–determined day count

To set the BUD:

  1. Select whether the product is Sterile or Non-sterile.
  2. Select the applicable BUD category from the dropdown.
  3. Enter the number of days in the BUD field. For Category 1 sterile products, the field auto-fills to 1 and is locked.
  4. Optionally enter a BUD note (e.g., "per stability study SS-2024-003") for auditing purposes.

Click Next when complete.


Step 4 — Storage conditions

Specify how the finished product must be stored to maintain potency and sterility.

Primary storage temperature — select one:

  • Room temperature (15–25 °C / 59–77 °F)
  • Refrigerate (2–8 °C / 36–46 °F)
  • Freeze (−25 to −10 °C / −13 to 14 °F)
  • Deep freeze (below −40 °C)

Additional conditions — check all that apply:

  • Protect from light — product must be stored in amber or opaque containers
  • Protect from moisture — desiccant required
  • Do not shake — applicable to suspensions

These conditions are printed on the batch record and are available as reference data during label generation.

Click Next when complete.


Step 5 — Risk level

Assign the risk level for this formula. Risk level affects which environmental monitoring (EM) data is required to release batches and which cleanroom zones must be used.

LevelTypical use
LowNon-sterile products, multi-dose oral preparations
MediumSterile preparations compounded without direct contact with the patient
HighSterile preparations for high-risk routes or patients with compromised immunity

Select the appropriate level and add any risk-level justification notes in the Notes field.

Click Save draft to complete the wizard.


After saving the draft

Once the wizard is complete, Clarix creates the formula in Draft status and assigns it a formula number (e.g., MF-2026-0001). You are taken directly to the formula detail page where you can:

  1. Add BOM lines on the Bill of Materials tab — add each ingredient with its target quantity and acceptable range.
  2. Author steps on the Steps tab — define the numbered manufacturing procedure.
  3. Submit for review once the formula is complete and ready for pharmacist approval.

Tip: You can save a draft formula and return to it later. Drafts remain editable indefinitely until submitted for review.

On this page